<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Voyager Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Voyager Therapeutics, Inc.

    Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $360,000,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Andre Turenne
    • FOUNDED
      2013
    • EMPLOYEES
      101-250
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    RehabPath Inc.

    RehabPath Inc.

    We exist to make the first step in a family’s path to recovery the right step thro...

    We exist to make the first step in a family’s p...

    Amount Raised:    $26,162.00
    Fundraising Status:    EC
    Filing Type:    CF
    Viking Therapeutics, Inc.

    Viking Therapeutics, Inc.

    Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the d...

    Viking Therapeutics is a clinical-stage biophar...

    Filing Type:    PU
    Oneva, Inc.

    Oneva, Inc.

    Today's adults juggle caring for aging parents and children while working full-tim...

    Today's adults juggle caring for aging parents ...

    Amount Raised:    $55,053.00
    Fundraising Status:    EC
    Filing Type:    CF
    Fibrocell Science Inc.

    Fibrocell Science Inc.

    Fibrocell is a cell and gene therapy company focused on improving the lives of peo...

    Fibrocell is a cell and gene therapy company fo...

    Filing Type:    PU
    InflaRx N.V.

    InflaRx N.V.

    InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on ap...

    InflaRx (Nasdaq: IFRX) is a clinical-stage biop...

    Filing Type:    PU
    Millendo Therapeutics, Inc.

    Millendo Therapeutics, Inc.

    Millendo Therapeutics is a late-stage biopharmaceutical company primarily focused ...

    Millendo Therapeutics is a late-stage biopharma...

    Filing Type:    PU
    Aquestive Therapeutics, Inc.

    Aquestive Therapeutics, Inc.

    Aquestive Therapeutics is a specialty pharmaceutical company that advances and com...

    Aquestive Therapeutics is a specialty pharmaceu...

    Filing Type:    PU
    Auris Medical Holding Ltd.

    Auris Medical Holding Ltd.

    We at Auris Medical are dedicated to developing novel pharmaceutical products for ...

    We at Auris Medical are dedicated to developing...

    Filing Type:    PU
    Therapix Biosciences Ltd.

    Therapix Biosciences Ltd.

    Therapix Biosciences Ltd. (NASDAQ: TRPX) is a specialty clinical-stage pharmaceuti...

    Therapix Biosciences Ltd. (NASDAQ: TRPX) is a s...

    Filing Type:    PU
    Genprex, Inc.

    Genprex, Inc.

    Genprex Inc is a U.S.-based clinical-stage gene therapy company. It is engaged in ...

    Genprex Inc is a U.S.-based clinical-stage gene...

    Filing Type:    PU
    Rocket Pharmaceuticals, Inc.

    Rocket Pharmaceuticals, Inc.

    Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company ...

    Rocket Pharmaceuticals, Inc. is an emerging, cl...

    Filing Type:    PU
    uniQure N.V.

    uniQure N.V.

    uniQure is delivering on the promise of gene therapy -- single treatments with pot...

    uniQure is delivering on the promise of gene th...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.